ACTU   $2.02  1.51% Market Closed After Close 1.91 -5.45%

Actuate Therapeutics, Inc.
Total Cash 351.71K
totalCashPerShare 0.018
EBITDA
Total Debt 6.90M
quickRatio 0.018
currentRatio 0.027
Total Revenue
debtToEquity
Revenue/Share
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -19.07M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 254.92M
forwardPE
floatShares 6.60M
sharesOutstanding 19.53M
sharesShort 13.17K
sharesShortPriorMonth 12.34K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.19%
heldPercentInstitutions 0.51%
Short Ratio help_outline 0.87%
shortPercentOfFloat
impliedSharesOutstanding
bookValue -67.577
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -28.82M
trailingEps -1.51%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 2
lastUpdated Nov. 2, 2024, 7:56 a.m.